Warning: We observe an increase of emails from fake travel portals like . "travelhosting.co.uk". We never send links to such portals so be vigilant!

8–11 Jun 2021 Online only
Europe/Berlin timezone
Note: Each session block has its own zoom session, so please choose the correct link from the timetable!

Hydrogen bonding network running through protein kinase investigated by neutron crystallography

9 Jun 2021, 13:00
2h
Poster Protein structure, function and dynamics Poster Session

Speaker

Chie Shibazaki (National Institutes for Quantum and Radiological Science and Technology)

Description

Casein kinase II (CK2), is a serine / threonine kinase ubiquitously distributed among eukaryotic cells, is known to be involved in the cell cycle and cell survival and proliferation. CK2 is one of the drug target proteins, because the relationship between CK2 over-expression and carcinogenesis and cancer metastasis has been pointed out. We aimed to elucidate the hydrogen bonding network involved in the catalytic reaction of CK2 and to obtain the knowledge of conformation of the hydrogen atom and hydration structure effective for the development of inhibitors. In this study, we prepared large crystals for neutron diffraction experiments of wild type CK2α (catalytic subunit). The large crystal of about 2 mm3 was obtained by the macro seeding method. After the dialysis of the obtained crystal against deuterium solvent, a neutron diffraction data were collected at FRMII BioDIFF(100 K) to resolution of 1.90 Å. Then, X-ray diffraction experiment at PF BL-5A was collected using the same crystal to resolution 1.10 Å for the joint refinement. As a result of neutron crystallography, an interesting hydrogen bonding network running through CK2α was found. This discovery can be expected to contribute to the development of an anticancer drug with a new inhibitory mechanism.

Primary author

Chie Shibazaki (National Institutes for Quantum and Radiological Science and Technology)

Co-authors

Ms Shimizu Rumi (National Institutes for Quantum and Radiological Science and Technology) Dr Shigeki Arai (National Institutes for Quantum and Radiological Science and Technology) Dr Motoyasu Adachi (National Institutes for Quantum and Radiological Science and Technology) Dr Ryota Kuroki (Japan Atomic Energy Agency) Dr Tobias Schrader Dr Andreas Ostermann (Heinz Maier-Leibnitz Zentrum (MLZ), Technische Universität München)

Presentation materials

There are no materials yet.